NGS Informatics Market Size, Share, Trends, Growth Outlook

NGS Informatics Market is estimated to increase at a Compounded Annual Growth Rate of 14.8% CAGR over the forecast period from 2024 to 2030

The NGS Informatics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (NGS Informatics Services, Data Analysis and Management Tool, Primary and Secondary Data Analysis Tools), By Application (Drug Discovery, Genetic Screening, Precision Medicine, Others), By End-User (Hospitals, Clinics, Research Institutes, Others).

An Introduction to NGS Informatics Market in 2024

In 2024, the market for Next-Generation Sequencing (NGS) informatics continues to expand, driven by the increasing adoption of genomic technologies in research, clinical diagnostics, and personalized medicine. NGS informatics encompasses a suite of bioinformatics tools, software platforms, and data analysis pipelines designed to process, analyze, and interpret massive volumes of genomic data generated by NGS platforms. These informatics solutions enable researchers and clinicians to extract meaningful insights from genomic datasets, including variant calling, structural variant analysis, gene expression profiling, pathway analysis, and functional annotation. Technological advancements in NGS informatics include the development of cloud-based computing platforms, machine learning algorithms, and artificial intelligence (AI) models for data integration, visualization, and predictive analytics, facilitating rapid and scalable genomic analysis workflows. Moreover, the integration of data standards, interoperability frameworks, and secure data sharing mechanisms enhances collaboration, reproducibility, and translational research efforts in genomics and precision medicine. With the growing demand for genomic testing, molecular diagnostics, and genomic-driven healthcare interventions, the market for NGS informatics is poised for continued growth and innovation, offering essential tools and resources for unlocking the potential of genomic medicine and advancing personalized healthcare.

Market Trend: Integration of Artificial Intelligence in NGS Informatics

A prominent trend in the NGS informatics market is the increasing integration of artificial intelligence (AI) and machine learning algorithms to enhance data analysis, interpretation, and clinical decision support in next-generation sequencing (NGS) workflows. As the volume and complexity of genomic data generated by NGS technologies continue to grow, there is a growing need for advanced informatics solutions that can efficiently process, analyze, and extract meaningful insights from large-scale genomic datasets. AI-based approaches offer opportunities to automate repetitive tasks, identify patterns, and predict clinical outcomes, enabling faster and more accurate interpretation of genomic data for research, diagnostics, and personalized medicine applications. This trend is driven by advancements in AI algorithms, deep learning models, and computational resources, which enable the development of NGS informatics platforms with enhanced scalability, accuracy, and usability. Additionally, collaborations between bioinformatics experts, data scientists, and healthcare providers facilitate the integration of AI-driven tools into NGS workflows, empowering researchers and clinicians to harness the power of genomic data for precision medicine initiatives and translational research endeavors. As the field of genomics and AI convergence continues to evolve, the market for NGS informatics is expected to witness significant growth and innovation, driven by the imperative to improve genomic data analysis and accelerate the translation of genomic discoveries into clinical insights and actionable interventions.

Market Driver: Expansion of Genomic Medicine and Personalized Healthcare

The primary driver propelling the NGS informatics market is the expansion of genomic medicine and personalized healthcare initiatives worldwide, driving the demand for advanced informatics solutions that enable efficient analysis, interpretation, and utilization of genomic data in clinical practice. Genomic sequencing technologies, including NGS, have revolutionized the field of molecular diagnostics, enabling comprehensive profiling of genetic variants, somatic mutations, and biomarkers associated with disease susceptibility, progression, and treatment response. This driver is fueled by the growing adoption of genomic sequencing in clinical settings, such as oncology, rare disease diagnosis, pharmacogenomics, and reproductive health, where genomic data inform therapeutic decision-making, patient stratification, and disease management strategies. Additionally, advancements in genomic research, precision oncology, and population genomics initiatives drive the demand for informatics platforms that can handle diverse genomic datasets, integrate multi-omics data, and support data sharing and collaboration across research institutions and healthcare systems. As healthcare systems prioritize value-based care, precision medicine, and genomic-driven approaches, the market for NGS informatics is expected to experience sustained growth and investment, driven by the imperative to improve patient outcomes and reduce healthcare costs through personalized interventions and targeted therapies.

Market Opportunity: Development of Clinical Decision Support Systems

An opportunity within the NGS informatics market lies in the development of clinical decision support systems (CDSS) that leverage AI-driven algorithms to provide real-time, evidence-based recommendations for genomic testing, interpretation, and treatment selection in clinical practice. Opportunities exist for informatics companies and healthcare providers to develop CDSS platforms that integrate genomic data, clinical phenotypes, and electronic health records (EHRs) to support clinical decision-making across diverse medical specialties and disease areas. CDSS solutions can facilitate variant annotation, pathogenicity assessment, and genotype-phenotype correlation analysis, enabling clinicians to prioritize actionable findings, interpret complex genomic data, and tailor treatment strategies to individual patient characteristics. Additionally, opportunities exist for CDSS platforms to incorporate real-world evidence, clinical trial data, and expert consensus guidelines to guide treatment decisions, monitor treatment response, and optimize patient outcomes in oncology, rare diseases, and other genomic-driven specialties. Collaborations between informatics vendors, healthcare institutions, and regulatory agencies can drive innovation and validation of CDSS solutions, ensuring interoperability, regulatory compliance, and clinical utility in supporting genomic medicine initiatives and personalized healthcare delivery. As the field of genomic informatics evolves towards clinical integration and decision support, the market presents opportunities for differentiation, market expansion, and leadership in delivering AI-driven informatics solutions that empower clinicians and improve patient care in the era of precision medicine.

NGS Informatics Market Share Analysis: Primary and Secondary Data Analysis Tools

The fast-growing segment within the NGS informatics market is primary and secondary data analysis tools. This growth is driven by several factors. Firstly, the increasing adoption of next-generation sequencing (NGS) technologies across various applications, including drug discovery, genetic screening, and precision medicine, generates vast amounts of raw sequencing data that require sophisticated bioinformatics tools for processing, analysis, and interpretation. Primary data analysis tools enable the initial processing of raw sequencing reads, including base calling, quality control, and alignment to reference genomes, while secondary data analysis tools facilitate downstream analyses, such as variant calling, gene expression quantification, pathway analysis, and variant annotation. Secondly, advancements in bioinformatics algorithms, software platforms, and cloud computing technologies have led to the development of highly scalable, efficient, and user-friendly data analysis tools that enable researchers and clinicians to derive meaningful insights from NGS data with improved accuracy, speed, and reproducibility. These tools encompass a wide range of functionalities, including read alignment, variant detection, de novo assembly, differential expression analysis, and pathway enrichment analysis, among others, thereby empowering users to perform comprehensive and complex analyses of genomic, transcriptomic, and epigenomic data sets. Additionally, the integration of primary and secondary data analysis tools into unified informatics pipelines or platforms streamlines the NGS data analysis workflow, enhances data interoperability, and facilitates data sharing and collaboration among researchers, clinicians, and bioinformaticians across different institutions and disciplines. Furthermore, the growing demand for personalized medicine, biomarker discovery, and translational research drives the adoption of NGS informatics solutions in hospitals, clinics, research institutes, and pharmaceutical companies, where they play a critical role in advancing our understanding of human genetics, disease mechanisms, and therapeutic targets, as well as in guiding clinical decision-making and patient care. Moreover, the expanding NGS market, coupled with the increasing complexity and scale of genomic data generated by emerging sequencing technologies and applications, creates opportunities for innovation and differentiation in the development of advanced data analysis tools tailored to specific research and clinical needs, thereby driving market growth and competitiveness in the NGS informatics sector. Overall, the combination of technological innovation, market demand, and clinical utility positions primary and secondary data analysis tools as the fast-growing segment within the NGS informatics market.

NGS Informatics Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAgilent Technologies Inc, BIOVIA, Dnanexus Inc, DNASTAR Inc, Eagle Genomics Ltd, F. Hoffmann-La Roche Ltd, Fabric Genomics Inc, GENEWIZ Inc, IBM Corp, Intrexon Bioinformatics Germany GmbH, llumina Inc, Partek Inc, PerkinElmer Inc, PierianDx Inc, Qiagen NV, Real Time Genomics Inc, Sapio Sciences, SoftGenetics LLC, Thermo Fischer Scientific Inc

NGS Informatics Market Segmentation

By Product and Services
NGS Informatics Services
Data Analysis and Management Tool
-Storage and Computing Tool
-Laboratory Information Management System (LIMS)
-Data Interpretation and Reporting Tools
Primary and Secondary Data Analysis Tools
By Application
Drug Discovery
Genetic Screening
Precision Medicine
Others
By End-User
Hospitals
Clinics
Research Institutes
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

NGS Informatics Market Companies

Agilent Technologies Inc
BIOVIA
Dnanexus Inc
DNASTAR Inc
Eagle Genomics Ltd
F. Hoffmann-La Roche Ltd
Fabric Genomics Inc
GENEWIZ Inc
IBM Corp
Intrexon Bioinformatics Germany GmbH
llumina Inc
Partek Inc
PerkinElmer Inc
PierianDx Inc
Qiagen NV
Real Time Genomics Inc
Sapio Sciences
SoftGenetics LLC
Thermo Fischer Scientific Inc

Reasons to Buy the NGS Informatics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the NGS Informatics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the NGS Informatics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 NGS Informatics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global NGS Informatics Market Size Outlook, $ Million, 2021 to 2030
3.2 NGS Informatics Market Outlook by Type, $ Million, 2021 to 2030
3.3 NGS Informatics Market Outlook by Product, $ Million, 2021 to 2030
3.4 NGS Informatics Market Outlook by Application, $ Million, 2021 to 2030
3.5 NGS Informatics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of NGS Informatics Industry
4.2 Key Market Trends in NGS Informatics Industry
4.3 Potential Opportunities in NGS Informatics Industry
4.4 Key Challenges in NGS Informatics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global NGS Informatics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global NGS Informatics Market Outlook by Segments
7.1 NGS Informatics Market Outlook by Segments, $ Million, 2021- 2030
By Product and Services
NGS Informatics Services
Data Analysis and Management Tool
-Storage and Computing Tool
-Laboratory Information Management System (LIMS)
-Data Interpretation and Reporting Tools
Primary and Secondary Data Analysis Tools
By Application
Drug Discovery
Genetic Screening
Precision Medicine
Others
By End-User
Hospitals
Clinics
Research Institutes
Others

8 North America NGS Informatics Market Analysis and Outlook To 2030
8.1 Introduction to North America NGS Informatics Markets in 2024
8.2 North America NGS Informatics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America NGS Informatics Market size Outlook by Segments, 2021-2030
By Product and Services
NGS Informatics Services
Data Analysis and Management Tool
-Storage and Computing Tool
-Laboratory Information Management System (LIMS)
-Data Interpretation and Reporting Tools
Primary and Secondary Data Analysis Tools
By Application
Drug Discovery
Genetic Screening
Precision Medicine
Others
By End-User
Hospitals
Clinics
Research Institutes
Others

9 Europe NGS Informatics Market Analysis and Outlook To 2030
9.1 Introduction to Europe NGS Informatics Markets in 2024
9.2 Europe NGS Informatics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe NGS Informatics Market Size Outlook by Segments, 2021-2030
By Product and Services
NGS Informatics Services
Data Analysis and Management Tool
-Storage and Computing Tool
-Laboratory Information Management System (LIMS)
-Data Interpretation and Reporting Tools
Primary and Secondary Data Analysis Tools
By Application
Drug Discovery
Genetic Screening
Precision Medicine
Others
By End-User
Hospitals
Clinics
Research Institutes
Others

10 Asia Pacific NGS Informatics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific NGS Informatics Markets in 2024
10.2 Asia Pacific NGS Informatics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific NGS Informatics Market size Outlook by Segments, 2021-2030
By Product and Services
NGS Informatics Services
Data Analysis and Management Tool
-Storage and Computing Tool
-Laboratory Information Management System (LIMS)
-Data Interpretation and Reporting Tools
Primary and Secondary Data Analysis Tools
By Application
Drug Discovery
Genetic Screening
Precision Medicine
Others
By End-User
Hospitals
Clinics
Research Institutes
Others

11 South America NGS Informatics Market Analysis and Outlook To 2030
11.1 Introduction to South America NGS Informatics Markets in 2024
11.2 South America NGS Informatics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America NGS Informatics Market size Outlook by Segments, 2021-2030
By Product and Services
NGS Informatics Services
Data Analysis and Management Tool
-Storage and Computing Tool
-Laboratory Information Management System (LIMS)
-Data Interpretation and Reporting Tools
Primary and Secondary Data Analysis Tools
By Application
Drug Discovery
Genetic Screening
Precision Medicine
Others
By End-User
Hospitals
Clinics
Research Institutes
Others
12 Middle East and Africa NGS Informatics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa NGS Informatics Markets in 2024
12.2 Middle East and Africa NGS Informatics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa NGS Informatics Market size Outlook by Segments, 2021-2030
By Product and Services
NGS Informatics Services
Data Analysis and Management Tool
-Storage and Computing Tool
-Laboratory Information Management System (LIMS)
-Data Interpretation and Reporting Tools
Primary and Secondary Data Analysis Tools
By Application
Drug Discovery
Genetic Screening
Precision Medicine
Others
By End-User
Hospitals
Clinics
Research Institutes
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
BIOVIA
Dnanexus Inc
DNASTAR Inc
Eagle Genomics Ltd
F. Hoffmann-La Roche Ltd
Fabric Genomics Inc
GENEWIZ Inc
IBM Corp
Intrexon Bioinformatics Germany GmbH
llumina Inc
Partek Inc
PerkinElmer Inc
PierianDx Inc
Qiagen NV
Real Time Genomics Inc
Sapio Sciences
SoftGenetics LLC
Thermo Fischer Scientific Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product and Services
NGS Informatics Services
Data Analysis and Management Tool
-Storage and Computing Tool
-Laboratory Information Management System (LIMS)
-Data Interpretation and Reporting Tools
Primary and Secondary Data Analysis Tools
By Application
Drug Discovery
Genetic Screening
Precision Medicine
Others
By End-User
Hospitals
Clinics
Research Institutes
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)